These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12378122)

  • 1. Weight gain and serum leptin levels in patients on lithium treatment.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Neuropsychobiology; 2002; 46(2):67-9. PubMed ID: 12378122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced weight gain: bipolar disorder and leptin.
    McIntyre RS; Mancini DA; Basile VS; Srinivasan J; Kennedy SH
    J Clin Psychopharmacol; 2003 Aug; 23(4):323-7. PubMed ID: 12920406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression.
    Bopp SK; Heilbronner U; Schlattmann P; Mühleisen TW; Bschor T; Richter C; Steinacher B; Stamm TJ; Merkl A; Herms S; Köhler S; Sterzer P; Hellweg R; Heinz A; Cichon S; Lang UE; Schulze TG; Adli M; Ricken R
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):211-221. PubMed ID: 30554862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin and cholesterol levels in patients with bipolar disorder.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Bayik Y
    Neuropsychobiology; 2002; 46(4):176-9. PubMed ID: 12566933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin serum concentrations are associated with weight gain during lithium augmentation.
    Ricken R; Bopp S; Schlattmann P; Himmerich H; Bschor T; Richter C; Stamm TJ; Bauer F; Heinz A; Hellweg R; Lang UE; Adli M
    Psychoneuroendocrinology; 2016 Sep; 71():31-5. PubMed ID: 27235637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder.
    Farooq S; Nazar Z; Akhtar J; Irfan M; Subhan F; Ahmed Z; Khan EH; Naeem F
    Int Clin Psychopharmacol; 2010 Nov; 25(6):323-7. PubMed ID: 20827213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium-induced changes in the body mass index.
    Mathew B; Rao JM; Sundari U
    Acta Psychiatr Scand; 1989 Dec; 80(6):538-40. PubMed ID: 2618775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ramadan and bipolar disorder: Example of circadian rhythm disturbance and its impact on patients with bipolar disorders].
    Eddahby S; Kadri N; Moussaoui D
    Encephale; 2013 Sep; 39(4):306-12. PubMed ID: 23545475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function in patients maintained on lithium.
    Hatterer JA; Kocsis JH; Stokes PE
    Psychiatry Res; 1988 Dec; 26(3):249-57. PubMed ID: 3146759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relationship between leptin increase and improvement in depressive symptoms in anorexia nervosa.
    Rybakowski F; Slopien A; Tyszkiewicz-Nwafor M
    Neuro Endocrinol Lett; 2014; 35(1):64-7. PubMed ID: 24625915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.